Scholars@Duke

Self-replicating messenger RNA based cancer immunotherapy.

Publication ,  Journal Article
Lyerly, HK
Published in: Cancer Gene Ther
June 2023
Published version (DOI) Link to item

Duke Scholars

Herbert Kim Lyerly
Author Herbert Kim Lyerly Surgery, Surgical Sciences

Published In

Cancer Gene Ther

DOI

10.1038/s41417-023-00619-w

EISSN

1476-5500

Publication Date

June 2023

Volume

30

Issue

6

Start / End Page

769 / 770

Location

England

Related Subject Headings

  • RNA, Messenger
  • RNA
  • Oncology & Carcinogenesis
  • Neoplasms
  • Immunotherapy
  • Humans
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyerly, H. K. (2023). Self-replicating messenger RNA based cancer immunotherapy. Cancer Gene Ther, 30(6), 769–770. https://doi.org/10.1038/s41417-023-00619-w
Lyerly, Herbert Kim. “Self-replicating messenger RNA based cancer immunotherapy.” Cancer Gene Ther 30, no. 6 (June 2023): 769–70. https://doi.org/10.1038/s41417-023-00619-w.
Lyerly HK. Self-replicating messenger RNA based cancer immunotherapy. Cancer Gene Ther. 2023 Jun;30(6):769–70.
Lyerly, Herbert Kim. “Self-replicating messenger RNA based cancer immunotherapy.” Cancer Gene Ther, vol. 30, no. 6, June 2023, pp. 769–70. Pubmed, doi:10.1038/s41417-023-00619-w.
Lyerly HK. Self-replicating messenger RNA based cancer immunotherapy. Cancer Gene Ther. 2023 Jun;30(6):769–770.

Published In

Cancer Gene Ther

DOI

10.1038/s41417-023-00619-w

EISSN

1476-5500

Publication Date

June 2023

Volume

30

Issue

6

Start / End Page

769 / 770

Location

England

Related Subject Headings

  • RNA, Messenger
  • RNA
  • Oncology & Carcinogenesis
  • Neoplasms
  • Immunotherapy
  • Humans
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis